Oncodesign Precision Medicine S.A.
No trades
No trades
Compare with Oncodesign Precision Medicine S.A.
0.307 EUR
5.48 M EUR
261.15 K EUR
Details
Sector
Industry
CEO
Philippe Genne
Website
Headquarters
Dijon
Founded
2020
IPO date
Oct 5, 2022
ISIN
FR001400CM63
FIGI
BBG019VR0TK9
Identifiers
ISIN FR001400CM63
Oncodesign Precision Medicine SA engages in manufacturing precision medicine. It develops a precision medicine platform dedicated to cancerous diseases and other diseases without a therapeutic solution. The firm’s innovative platform for the selection of new therapeutic targets has been developed based on patient data and through a novel approach using artificial intelligence. The company was founded by Philippe Genne, Jan Hoflack, and Karine Ligne on December 15, 2020 and is headquartered in Dijon, France.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of ALOPM is 0.326 EUR — it has decreased by −0.31% in the past 24 hours. Watch Oncodesign Precision Medicine S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Oncodesign Precision Medicine S.A. stocks are traded under the ticker ALOPM.
ALOPM stock has risen by 4.15% compared to the previous week, the month change is a 1.88% rise, over the last year Oncodesign Precision Medicine S.A. has showed a −25.57% decrease.
ALOPM reached its all-time high on Nov 8, 2022 with the price of 2.500 EUR, and its all-time low was 0.280 EUR and was reached on Jun 18, 2025. View more price dynamics on ALOPM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALOPM stock is 0.61% volatile and has beta coefficient of 0.13. Track Oncodesign Precision Medicine S.A. stock price on the chart and check out the list of the most volatile stocks — is Oncodesign Precision Medicine S.A. there?
Today Oncodesign Precision Medicine S.A. has the market capitalization of 6.24 M, it has decreased by −1.55% over the last week.
Yes, you can track Oncodesign Precision Medicine S.A. financials in yearly and quarterly reports right on TradingView.
ALOPM net income for the last half-year is −4.37 M EUR, while the previous report showed 9.85 M EUR of net income which accounts for 0.00% change. Track more Oncodesign Precision Medicine S.A. financial stats to get the full picture.
No, ALOPM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 12, 2026, the company has 13 employees. See our rating of the largest employees — is Oncodesign Precision Medicine S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Oncodesign Precision Medicine S.A. EBITDA is 4.83 M EUR, and current EBITDA margin is 1.85 K%. See more stats in Oncodesign Precision Medicine S.A. financial statements.
Like other stocks, ALOPM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncodesign Precision Medicine S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncodesign Precision Medicine S.A. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncodesign Precision Medicine S.A. stock shows the sell signal. See more of Oncodesign Precision Medicine S.A. technicals for a more comprehensive analysis.